scholarly article | Q13442814 |
P356 | DOI | 10.1158/0008-5472.CAN-05-1019 |
P698 | PubMed publication ID | 16103057 |
P50 | author | Jeremy Chien | Q37378363 |
P2093 | author name string | Viji Shridhar | |
William A Cliby | |||
Kriste A Lewis | |||
Bijoy Thomas | |||
Sally Mullany | |||
Ralitsa Loewen | |||
P433 | issue | 16 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | heterozygosity | Q124059385 |
DNA mismatch repair | Q2984243 | ||
P304 | page(s) | 7091-7095 | |
P577 | publication date | 2005-08-01 | |
P1433 | published in | Cancer Research | Q326097 |
P1476 | title | Heterozygous ATR mutations in mismatch repair-deficient cancer cells have functional significance | |
P478 | volume | 65 |
Q43177489 | ATR and H2AX cooperate in maintaining genome stability under replication stress |
Q27851472 | ATR mutation in endometrioid endometrial cancer is associated with poor clinical outcomes |
Q36918246 | ATR signalling: more than meeting at the fork |
Q40257591 | Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection |
Q34458291 | An ex vivo assay of XRT-induced Rad51 foci formation predicts response to PARP-inhibition in ovarian cancer |
Q35423647 | Analysis of mutations that dissociate G(2) and essential S phase functions of human ataxia telangiectasia-mutated and Rad3-related (ATR) protein kinase |
Q30356815 | Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study |
Q41785468 | Ataxia telangiectasia and rad3-related kinase contributes to cell cycle arrest and survival after cisplatin but not oxaliplatin |
Q40122149 | Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. |
Q40120694 | Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling |
Q34676703 | Combining ATR suppression with oncogenic Ras synergistically increases genomic instability, causing synthetic lethality or tumorigenesis in a dosage-dependent manner |
Q35779036 | Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins |
Q38716604 | DNA Damage Response-Independent Role for MDC1 in Maintaining Genomic Stability |
Q28388312 | DNA damage response genes and the development of cancer metastasis |
Q36204976 | DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination |
Q38061847 | DNA repair dysregulation from cancer driver to therapeutic target |
Q92711548 | Extreme intratumour heterogeneity and driver evolution in mismatch repair deficient gastro-oesophageal cancer |
Q34422582 | Genetic determinants at the interface of cancer and neurodegenerative disease |
Q35843205 | Germline mutation in ATR in autosomal- dominant oropharyngeal cancer syndrome. |
Q37185705 | Haploinsufficiency of DNA Damage Response Genes and their Potential Influence in Human Genomic Disorders |
Q37530284 | Is activation of the intra-S checkpoint in human fibroblasts an important factor in protection against UV-induced mutagenesis? |
Q54740910 | Mice hypomorphic for Atr have increased DNA damage and abnormal checkpoint response. |
Q53526795 | Mutations in the ataxia telangiectasia and rad3-related-checkpoint kinase 1 DNA damage response axis in colon cancers. |
Q35640593 | Oncogenic stress sensitizes murine cancers to hypomorphic suppression of ATR |
Q90422428 | Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing |
Q40026743 | Rapid identification of somatic mutations in colorectal and breast cancer tissues using mismatch repair detection (MRD). |
Q37327269 | Reduced ATR or Chk1 expression leads to chromosome instability and chemosensitization of mismatch repair-deficient colorectal cancer cells |
Q37936675 | Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication |
Q57458037 | Sirtuin 1-mediated deacetylation of XPA DNA repair protein enhances its interaction with ATR protein and promotes cAMP-induced DNA repair of UV damage |
Q35128547 | Targeting lung cancer through inhibition of checkpoint kinases |
Q36151896 | The genomics and genetics of endometrial cancer |
Q26745686 | Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy |
Search more.